Biggest changeCONSOLIDATED GAAP to Non-GAAP Reconciliation For the Fiscal Year Ended September 24, 2022 Net sales (GAAP) Effect of acquisitions & divestitures on net sales Net sales organic (in millions) Reported net sales FY 2022 $ 3,338.6 $ 146.9 $ 3,191.7 Reported net sales FY 2021 3,303.7 3.9 3,299.8 $ increase (decrease) $ 34.9 $ 143.0 $ (108.1) % increase (decrease) 1.1 % (3.3) % PET GAAP to Non-GAAP Reconciliation For the Fiscal Year Ended September 24, 2022 Net sales (GAAP) Effect of acquisitions & divestitures on net sales Net sales organic (in millions) Reported net sales FY 2022 $ 1,878.1 $ — $ 1,878.1 Reported net sales FY 2021 1,894.9 3.9 1,891.0 $ decrease $ (16.8) $ (3.9) $ (12.9) % decrease (0.9) % (0.7) % GARDEN GAAP to Non-GAAP Reconciliation For the Fiscal Year Ended September 24, 2022 Net sales (GAAP) Effect of acquisitions & divestitures on net sales Net sales organic (in millions) Reported net sales FY 2022 $ 1,460.5 $ 146.9 $ 1,313.6 Reported net sales FY 2021 1,408.8 — 1,408.8 $ increase (decrease) $ 51.7 $ 146.9 $ (95.2) % increase (decrease) 3.7 % (6.8) % 32 GAAP to non-GAAP Reconciliation Fiscal Year Ended September 24, 2022 (in thousands) Adjusted EBITDA Reconciliation Garden Pet Corp Total Net income attributable to Central Garden & Pet — — — $ 152,152 Interest expense, net — — — 57,534 Other expense — — — 3,596 Income tax expense — — — 46,234 Net income attributable to noncontrolling interest — — — 520 Sum of items below operating income — — — 107,884 Income (loss) from operations 153,956 208,924 (102,844) 260,036 Depreciation & amortization 36,583 38,960 5,405 80,948 Noncash stock-based compensation $ 25,817 $ 25,817 Adjusted EBITDA $ 190,539 $ 247,884 $ (71,622) $ 366,801 GAAP to non-GAAP Reconciliation Fiscal Year Ended September 25, 2021 (in thousands) Adjusted EBITDA Reconciliation Garden Pet Corp Total Net income attributable to Central Garden & Pet — — — $ 151,746 Interest expense, net — — — 58,182 Other expense — — — 1,506 Income tax expense — — — 42,035 Net income attributable to noncontrolling interest — — — 1,027 Sum of items below operating income — — — 102,750 Income (loss) from operations 138,755 208,201 (92,460) 254,496 Depreciation & amortization 33,050 36,952 4,725 74,727 Noncash stock-based compensation $ 23,127 $ 23,127 Adjusted EBITDA $ 171,805 $ 245,153 $ (64,608) $ 352,350 Inflation Our revenues and margins are dependent on various economic factors, including rates of inflation, energy costs, consumer attitudes toward discretionary spending, currency fluctuations, and other macro-economic factors which may impact levels of consumer spending.
Biggest changeOperating Income Reconciliation GAAP to Non-GAAP Reconciliation Fiscal Year Ended September 30, 2023 GAAP Adjustments (1)(2)(3) Non-GAAP (in thousands) Net sales $ 3,310,083 $ — $ 3,310,083 Cost of goods sold and occupancy 2,363,241 9,761 2,353,480 Gross profit 946,842 (9,761) 956,603 Selling, general and administrative expenses 736,196 6,798 729,398 Income from operations $ 210,646 $ (16,559) $ 227,205 29 GAAP to Non-GAAP Reconciliation For the Fiscal Year Ended Pet Segment Operating Income Reconciliation September 30, 2023 September 24, 2022 (in thousands) GAAP operating income $ 198,004 $ 208,924 Facility closure and intangible asset impairment (1)(3) 18,457 — Non-GAAP operating income $ 216,461 $ 208,924 GAAP operating margin 10.5 % 11.1 % Non-GAAP operating margin 11.5 % 11.1 % GAAP to Non-GAAP Reconciliation For the Fiscal Year Ended Garden Segment Operating Income Reconciliation September 30, 2023 September 24, 2022 (in thousands) GAAP operating income $ 123,455 $ 153,956 Garden independent distribution sale and intangible asset impairment (2)(3) (1,898) — Non-GAAP operating income $ 121,557 $ 153,956 GAAP operating margin 8.6 % 10.5 % Non-GAAP operating margin 8.5 % 10.5 % GAAP to Non-GAAP Reconciliation For the Fiscal Year Ended September 30, 2023 September 24, 2022 (in thousands, except per share amount) Net Income and Diluted Net Income Per Share Reconciliation GAAP net income attributable to Central Garden & Pet Company $ 125,643 $ 152,152 Pet facilities closures (1) 15,672 — Independent garden channel distribution sale and related facility closure (2) (5,844) — Intangible impairments (3) 6,731 — Tax effect of adjustments (3,705) — Non-GAAP net income attributable to Central Garden & Pet Company $ 138,497 $ 152,152 GAAP diluted net income per share $ 2.35 $ 2.80 Non-GAAP diluted net income per share $ 2.59 $ 2.80 Shares used in GAAP and non-GAAP diluted net income per share calculation 53,427 54,425 30 GAAP to non-GAAP Reconciliation Fiscal Year Ended September 30, 2023 Adjusted EBITDA Reconciliation Pet Garden Corp Total (in thousands) Net income attributable to Central Garden & Pet $ — $ — $ — $ 125,643 Interest expense, net — — — 49,663 Other income — — — (1,462) Income tax expense — — — 36,348 Net income attributable to noncontrolling interest — — — 454 Sum of items below operating income — — — 85,003 Income (loss) from operations 198,004 123,455 (110,813) 210,646 Depreciation & amortization 41,126 43,375 3,199 87,700 Noncash stock-based compensation — — 27,990 27,990 Non-GAAP adjustments (1)(2)(3) 18,457 (1,898) — 16,559 Adjusted EBITDA $ 257,587 $ 164,932 $ (79,624) $ 342,895 GAAP to non-GAAP Reconciliation Fiscal Year Ended September 24, 2022 Adjusted EBITDA Reconciliation Pet Garden Corp Total (in thousands) Net income attributable to Central Garden & Pet $ — $ — $ — $ 152,152 Interest expense, net — — — 57,534 Other expense — — — 3,596 Income tax expense — — — 46,234 Net income attributable to noncontrolling interest — — — 520 Sum of items below operating income — — — 107,884 Income (loss) from operations 208,924 153,956 (102,844) 260,036 Depreciation & amortization 38,960 36,583 5,405 80,948 Noncash stock-based compensation — — 25,817 25,817 Adjusted EBITDA $ 247,884 $ 190,539 $ (71,622) $ 366,801 Inflation Our revenues and margins are dependent on various economic factors, including rates of inflation, energy costs, interest rates, consumer attitudes toward discretionary spending, currency fluctuations, and other macro-economic factors which may impact levels of consumer spending.
Investing Activities Net cash used in investing activities decreased $756.4 million from $899.4 million in fiscal 2021 to $143.0 million in fiscal 2022. The decrease in cash used in investing activities was due primarily to acquisition activity in the prior year.
Net cash used in investing activities decreased $756.4 million from $899.4 million in fiscal 2021 to $143.0 million in fiscal 2022. The decrease in cash used in investing activities was due primarily to acquisition activity in the prior year.
The Guarantee of a Guarantor will be released: (1) upon any sale or other disposition of all or substantially all of the assets of that Guarantor (including by way of merger or consolidation), in accordance with the governing indentures, to any person other than the Company; (2) if such Guarantor merges with and into the Company, with the Company surviving such merger; (3) if the Guarantor is designated as an Unrestricted Subsidiary; or (4) if the Company exercises its legal defeasance option or covenant defeasance option or the discharge of the Company's obligations under the indentures in accordance with the terms of the indentures.
The Guarantee of a Guarantor will be released: (1) upon any sale or other disposition of all or substantially all of the assets of that Guarantor (including by way of merger or consolidation), in accordance with the governing indentures, to any person other than the Company; (2) if such Guarantor merges with and into the Company, with the Company surviving such merger; (3) if such Guarantor is designated as an Unrestricted Subsidiary; or (4) if the Company exercises its legal defeasance option or covenant defeasance option or the discharge of the Company's obligations under the indentures in accordance with the terms of the indentures.
The obligations of each Guarantor under its Guarantee shall be limited to the maximum amount, after giving effect to all other contingent and fixed liabilities of such Guarantor and to any collections from or payments made by or on behalf of any other Guarantor in 37 respect of the obligations of such Guarantor under the guarantee not constituting a fraudulent conveyance or fraudulent transfer under Federal or state law.
The obligations of each Guarantor under its Guarantee shall be limited to the maximum amount, after giving effect to all other contingent and fixed liabilities of such Guarantor and to any collections from or payments made by or on behalf of any other Guarantor in respect of the obligations of such Guarantor under the guarantee not constituting a fraudulent conveyance or fraudulent transfer under Federal or state law.
We may redeem some or all of the 2031 Notes at 35 our option, at any time on or after April 30, 2026 for 102.063%, on or after April 30, 2027 for 101.375%, on or after April 30, 2028 for 100.688% and on or after April 30, 2029 for 100.0%, plus accrued and unpaid interest.
We may redeem some or all of the 2031 Notes at our option, at any time on or after April 30, 2026 for 102.063%, on or after April 30, 2027 for 101.375%, on or after April 30, 2028 for 100.688% and on or after April 30, 2029 for 100.0%, plus accrued and unpaid interest.
In August 2019, our Board of Directors authorized a new share repurchase program to purchase up to $100 million of our common stock (the "2019 Repurchase Authorization"). The 2019 Repurchase Authorization has no fixed expiration date and expires when the amount authorized has been used or the Board withdraws its authorization.
In August 2019, our Board of Directors authorized a share repurchase program to purchase up to $100 million of our common stock (the "2019 Repurchase Authorization"). The 2019 Repurchase Authorization has no fixed expiration date and expires when the amount authorized has been used or the Board withdraws its authorization.
Future net sales and short-term growth rates are estimated for trade names based on management’s forecasted financial results which consider key business drivers such as specific revenue growth initiatives, market share changes and general economic factors such as consumer spending. During fiscal 2022, 2021 and 2020, we performed evaluations of the fair value of our indefinite-lived trade names and trademarks.
Future net sales and short-term growth rates are estimated for trade names based on management’s forecasted financial results which consider key business drivers such as specific revenue growth initiatives, market share changes and general economic factors such as consumer spending. During fiscal 2023, 2022 and 2021, we performed evaluations of the fair value of our indefinite-lived trade names and trademarks.
As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our lawn and garden businesses are highly seasonal with approximately 66% of our Garden segment’s net sales occurring during the second and third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods.
As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our lawn and garden businesses are highly seasonal with approximately 67% of our Garden segment’s net sales occurring during the second and third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods.
We incurred approximately $4.6 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 notes. The 2028 Notes require semiannual interest payments on February 1 and August 1.
We incurred approximately $4.8 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes. The 2028 Notes require semiannual interest payments on February 1 and August 1.
Substantially all of the Garden segment’s operating income is typically generated in this period. 33 Liquidity and Capital Resources We have financed our growth through a combination of internally generated funds, bank borrowings, supplier credit, and sales of equity and debt securities to the public.
Substantially all of the Garden segment’s operating income is typically generated in this period. 31 Liquidity and Capital Resources We have financed our growth through a combination of internally generated funds, bank borrowings, supplier credit, and sales of equity and debt securities to the public.
We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluation.
We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluations.
Borrowings under the Amended Credit Facility will bear interest at an index based on LIBOR (which will not be less than 0.00%) or, at our option, the Base Rate, plus, in either case, an applicable margin based on our usage under the credit facility.
Borrowings under the Amended Credit Facility will bear interest at an index based on SOFR (which will not be less than 0.00%) or, at our option, the Base Rate, plus, in either case, an applicable margin based on our usage under the credit facility.
The increase in cash used by financing activities during the current year was due primarily to our prior year issuance of $500 million of our 2030 Notes in October 2020 and $400 million of our 2031 Notes in April 2021, partially offset by the prior year repayment of our 2023 Notes and the corresponding premium paid on extinguishment as well as debt issuance costs incurred on the issuances of the 2030 Notes and 2031 Notes.
The increase in cash used in financing activities during the fiscal 2022 was due primarily to our prior year issuance of $500 million of our 2030 Notes in October 2020 and $400 million of our 2031 Notes in April 2021, partially offset by the prior year repayment of our 2023 Notes and the corresponding premium paid on extinguishment as well as debt issuance costs incurred on the issuances of the 2030 Notes and 2031 Notes.
In connection with our annual goodwill impairment testing performed during fiscal 2022, 2021 and 2020, we made a qualitative evaluation about the likelihood of goodwill impairment to determine whether it was necessary to calculate the estimated fair values of our reporting units under the quantitative goodwill impairment test.
In connection with our annual goodwill impairment testing performed during fiscal 2022, we made a qualitative evaluation about the likelihood of goodwill impairment to determine whether it was necessary to calculate the estimated fair values of our reporting units under the quantitative goodwill impairment test.
In fiscal 2022, our consolidated net sales were $3.3 billion, of which our Pet segment, or Pet, accounted for approximately $1.9 billion and our Garden segment, or Garden, accounted for approximately $1.4 billion.
In fiscal 2023, our consolidated net sales were $3.3 billion, of which our Pet segment, or Pet, accounted for approximately $1.9 billion and our Garden segment, or Garden, accounted for approximately $1.4 billion.
We were in compliance with all financial covenants as of September 24, 2022. $300 Million, 5.125% Senior Notes due 2028 On December 14, 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). We used the net proceeds from the offering to finance acquisitions and for general corporate purposes.
We were in compliance with all financial covenants as of September 30, 2023. $300 Million, 5.125% Senior Notes due 2028 On December 14, 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). We used the net proceeds from the offering to finance acquisitions and for general corporate purposes.
We were in compliance with all financial covenants under the Amended Credit Facility as of September 24, 2022. Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities Central (the "Parent/Issuer") issued $400 million of 2031 Notes in April 2021, $500 million of 2030 Notes in October 2020, and $300 million of 2028 Notes in December 2017.
We were in compliance with all financial covenants under the Amended Credit Facility as of September 30, 2023. Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities Central (the "Parent/Issuer") issued $400 million of 2031 Notes in April 2021, $500 million of 2030 Notes in October 2020, and $300 million of 2028 Notes in December 2017.
We incurred approximately $2.4 million of debt issuance costs in conjunction with this transaction, which included lender fees and legal expenses. The debt issuance costs are being amortized over the term of the Amended Credit Facility.
We incurred approximately $2.4 million of debt issuance costs in conjunction with the Amended Credit Agreement, which included lender fees and legal expenses. The debt issuance costs are being amortized over the term of the Amended Credit Facility.
The 2028 Notes contain customary high-yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of September 24, 2022. 36 Asset-Based Loan Facility Amendment On December 16, 2021, we entered into a Third Amended and Restated Credit Agreement (“Amended Credit Agreement”).
The 2028 Notes contain customary high-yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all covenants as of September 30, 2023. Asset-Based Loan Facility Amendment On December 16, 2021, we entered into a Third Amended and Restated Credit Agreement (“Amended Credit Agreement”).
See Note 11 - Long-Term Debt to the consolidated financial statements for further discussion of long-term debt. (2) Estimated interest payments to be made on our 2028 Notes, our 2030 Notes and our 2031 Notes. See Note 11 - Long-Term Debt to the consolidated financial statements for description of interest rate terms.
See Note 11 - Long-Term Debt to the consolidated financial statements for further discussion of long-term debt. (2) Estimated interest payments to be made on our 2028 Notes, our 2030 Notes and our 2031 Notes.
Base Rate is defined as the highest of (a) the Truist prime rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month LIBOR plus 1.00% and (d) 0.00%.
Base Rate is defined as the 34 highest of (a) the Truist prime rate, (b) the Federal Funds Rate plus 0.50%, (c) one-month SOFR plus 1.00% and (d) 0.00%.
Letter of credit fees at the applicable margin on the average undrawn and unreimbursed amount of letters of credit shall be payable quarterly and a facing fee of 0.125% shall be payable quarterly for the stated amount of each letter of credit. We are also required to pay certain fees to the administrative agent under the Amended Credit Facility.
Standby letter of credit fees accruing at the applicable margin on the average undrawn and unreimbursed amounts of standby letters of credit are payable quarterly, and a facing fee of 0.125% is payable quarterly for the stated amount of each letter of credit. We are also required to pay certain fees to the administrative agent under the Amended Credit Facility.
The 2028 Notes are unconditionally guaranteed on a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our senior secured revolving credit facility or who guarantee the 2023 Notes.
The 2028 Notes are unconditionally guaranteed on a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our Amended Credit Facility.
Debt repayments do not reflect the unamortized portion of deferred financing costs associated with the 2028 Notes, 2030 Notes and 2031 Notes of approximately $14.1 million as of September 24, 2022, of which, $2.5 million is amortizable until February 2028, $6.4 million is amortizable until October 2030 and $5.2 million is amortizable until April 2031, and is included in the carrying value of the long-term debt.
Debt repayments do not reflect the unamortized portion of deferred financing costs associated with the 2028 Notes, 2030 Notes and 2031 Notes of approximately $12.2 million as of September 30, 2023, of which $2.0 million is amortizable until February 2028, $5.6 million is amortizable until October 2030 and $4.6 million is amortizable until April 2031, and is included in the carrying value of the long-term debt.
To encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended credit terms and/or promotional discounts. Operating Activities Net cash used in operating activities increased $284.8 million, from $250.8 million of cash provided by operating activities in fiscal 2021 to $34.0 million of cash used in operating activities in fiscal 2022.
To encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended credit terms and/or promotional discounts. Operating Activities Net cash provided by operating activities increased $415.6 million, from $34.0 million of cash used in operating activities in fiscal 2022 to $381.6 million of cash provided by operating activities in fiscal 2023.
The 2030 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our senior secured revolving credit facility or guarantee our other debt.
The 2030 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our Amended Credit Facility.
The Amended Credit Facility is subject to a borrowing base that is calculated using a formula based upon eligible receivables and inventory, and at our election, eligible real property, minus certain reserves. We did not draw down any commitments under the Amended Credit Facility upon closing. Proceeds of the Amended Credit Facility will be used for general corporate purposes.
The Amended Credit Facility is subject to a borrowing base that is calculated using a formula based upon eligible receivables and inventory, and at our election, eligible real property, minus certain reserves. Proceeds of the Amended Credit Facility will be used for general corporate purposes.
During fiscal 2021, inflation was broad-based and we saw significant increases across commodity and material costs, freight and labor. During fiscal 2020, we saw more moderate increases to commodity, labor and freight costs. Weather and Seasonality Our sales of lawn and garden products are influenced by weather and climate conditions in the different markets we serve.
During fiscal 2021, inflation was broad-based and we saw significant increases across commodity and material costs, freight and labor. Weather and Seasonality Our sales of lawn and garden products are influenced by weather and climate conditions in the different markets we serve. Our Garden segment’s business is highly seasonal.
We incurred approximately $8.0 million of debt issuance costs associated with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2030 Notes.
We incurred approximately $8.0 million of debt issuance costs associated with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2030 Notes. The 2030 Notes require semiannual interest payments on October 15 and April 15.
We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results.
We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable.
As of September 24, 2022, there were no borrowings outstanding and no letters of credit outstanding under the Amended Credit Facility. Outside of the Amended Credit Facility, there were other letters of credit of $1.3 million outstanding as of September 24, 2022.
As of September 30, 2023, there were no borrowings outstanding and no letters of credit outstanding under the Amended Credit Facility. Outside of the Amended Credit Facility, there were other standby and commercial letters of credit of $1.3 million outstanding as of September 30, 2023.
In fiscal years 2020 through 2022, we have been adversely impacted by rising input costs related to inflation, particularly relating to grain and seed prices, fuel prices and the ingredients used in our garden controls and fertilizer business as well as heightened import costs such as shipping container costs and tariffs.
In fiscal years 2021 through 2023, we were adversely impacted by high input costs due to inflation, particularly relating to prices for grain and seed, fuel and the ingredients used in our garden controls and fertilizer business as well as heightened import costs such as shipping container costs and tariffs.
Other expense was $3.6 million for fiscal 2022 compared to $1.5 million for fiscal 2021, due primarily to foreign currency losses in fiscal 2022. Income Tax Our effective income tax rate was 23.2% for fiscal 2022 compared to 21.6% for fiscal 2021.
Other income (expense) was $1.5 million of income in fiscal 2023 compared to an expense of $3.6 million for fiscal 2022, due primarily to foreign currency gains in fiscal 2023 as compared to foreign currency losses in fiscal 2022. Income Tax Our effective income tax rate was 22.4% for fiscal 2023 compared to 23.2% for fiscal 2022.
Fiscal 2021 Compared to Fiscal 2020 For a discussion of our results of operations in fiscal 2021 compared to fiscal 2020, please see Item 7 of our Annual Report on Form 10-K for the fiscal year ended September 25, 2021 filed with the SEC.
Fiscal 2022 Compared to Fiscal 2021 For a discussion of our results of operations in fiscal 2022 compared to fiscal 2021, please see Item 7 of our Annual Report on Form 10-K for the fiscal year ended September 24, 2022 filed with the SEC. Use of Non-GAAP Financial Measures We report our financial results in accordance with GAAP.
The Equity Dilution Authorization has no fixed expiration date and expires when the Board withdraws its authorization. As of September 25, 2022, we had authorization remaining to repurchase up to 0.1 million shares under our Equity Dilution Authorization. Total Debt At September 24, 2022, our total debt outstanding was $1,186.6 million versus $1,185.8 million at September 25, 2021.
The Equity Dilution Authorization has no fixed expiration date and expires when the Board withdraws its authorization. As of September 30, 2023, we did not have any shares remaining to repurchase under our Equity Dilution Authorization. Total Debt At September 30, 2023, our total debt outstanding was $1,188.2 million versus $1,186.6 million at September 24, 2022.
Net availability under the Amended Credit Facility was approximately $517 million as of September 24, 2022. The Amended Credit Facility includes a $50 million sublimit for the issuance of standby letters of credit and a $75 million sublimit for short-notice borrowings.
Net availability under the Amended Credit Facility was approximately $493 million as of September 30, 2023. The Amended Credit Facility includes a $50 million sublimit for the issuance of standby letters of credit and a $75 million sublimit for Swing Loan borrowings.
We believe the adjustment of these expenses supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance. • Loss on sale of business: we have excluded the impact of the loss on the sale of a business as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods.
We believe the adjustment of closure costs supplements the GAAP information with a measure that may be used to assess the performance of our ongoing operations. 28 • Gain on sale of a business or service line: we exclude the impact of the gain on the sale of a business as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods.
As of September 24, 2022, no repurchases had been made under the $100 million 2019 Repurchase Authorization. In February 2019, the Board of Directors authorized us to make supplemental purchases to minimize dilution resulting from issuances under our equity compensation plans (the "Equity Dilution Authorization").
As of September 30, 2023, we had $83.2 million remaining under our 2019 Repurchase Authorization. In February 2019, the Board of Directors authorized us to make supplemental purchases to minimize dilution resulting from issuances under our equity compensation plans (the "Equity Dilution Authorization").
We expect that our principal sources of funds will be cash generated from our operations, proceeds from our debt and equity offerings, and, if necessary, borrowings under our $750 million asset backed loan facility.
We also increased open market purchases of our common stock during fiscal 2022 as compared to fiscal 2021. We expect that our principal sources of funds will be cash generated from our operations, proceeds from our debt and equity offerings, and, if necessary, borrowings under our $750 million asset backed loan facility.
Use of Non-GAAP Financial Measures We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including adjusted EBITDA, organic sales, and non-GAAP net income and diluted net income per share.
However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including adjusted EBITDA, non-GAAP operating income, and non-GAAP net income and diluted net income per share.
The following table indicates each class of similar products which represented approximately 10% or more of our consolidated net sales in the fiscal years presented: Category 2022 2021 2020 (in millions) Other garden products $ 865.3 $ 876.6 $ 491.7 Other pet products 765.9 767.0 821.1 Other manufacturers' products 730.2 749.1 600.7 Dog & cat products 542.9 570.9 502.1 Wild bird 434.3 340.1 — (1) Controls & fertilizer products — (1) — (1) 279.9 Total $ 3,338.6 $ 3,303.7 $ 2,695.5 (1) The product category was less than 10% of our consolidated net sales in the period.
The following table indicates each class of similar products which represented approximately 10% or more of our consolidated net sales in the fiscal years presented: Category 2023 2022 2021 (in millions) Other garden products $ 832.2 $ 865.3 $ 876.6 Other pet products 699.4 765.9 767.0 Other manufacturers' products 734.9 730.2 749.1 Dog & cat products 568.6 542.9 570.9 Wild bird 475.0 434.3 340.1 Total $ 3,310.1 $ 3,338.6 $ 3,303.7 Pet net sales decreased $0.9 million, to $1,877.2 million in fiscal 2023 from $1,878.1 million in fiscal 2022.
Stock Repurchases During fiscal 2022, we repurchased approximately 1.4 million shares of our non-voting common stock (CENTA) on the open market at an aggregate cost of approximately $56.2 million, or $40.79 per share, and approximately 39,000 shares of our voting common stock (CENT) on the open market at an aggregate cost of approximately $1.6 million, or $39.72 per share.
Stock Repurchases During fiscal 2023, we repurchased approximately 0.6 million shares of our non-voting common stock (CENTA) on the open market at an aggregate cost of approximately $22.2 million, or $35.31 per share, and approximately 0.2 million of our voting common stock (CENT) on the open market at an aggregate cost of approximately $8.5 million, or $37.31 per share.
In presenting the summarized financial statements, the equity method of accounting has been applied to the Parent/Issuer's interests in the Guarantor Subsidiaries. The summarized information excludes financial information of the Non-Guarantors, including earnings from and investments in these entities.
In presenting the summarized financial statements, the equity method of accounting has been applied to the Parent/Issuer's interests in the Guarantor Subsidiaries.
The 2031 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of September 24, 2022.
The 2031 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions.
We may redeem some or all of the 2031 Notes at anytime, at our option, prior to April 30, 2026, at the principal amount plus a "make whole" premium.
The 2031 Notes were issued in a private placement under Rule 144A and will not be registered under the Securities Act of 1933. We may redeem some or all of the 2031 Notes at anytime, at our option, prior to April 30, 2026, at the principal amount plus a "make whole" premium.
Our Garden segment’s business is highly seasonal. In fiscal 2022, approximately 66% of our Garden segment’s net sales and 59% of our total net sales occurred during our second and third fiscal quarters.
In fiscal 2023, approximately 67% of our Garden segment’s net sales and 58% of our total net sales occurred during our second and third fiscal quarters.
Financing Activities Net cash used by financing activities increased $487.3 million from $420.5 million of cash provided in fiscal 2021 to $66.8 million of cash used in fiscal 2022.
The decrease in cash used by financing activities during the current year was due primarily to lower stock repurchase activity in fiscal 2023 compared to fiscal 2022. Net cash used in financing activities increased $487.3 million from $420.5 million of cash provided in fiscal 2021 to $66.8 million of cash used in fiscal 2022.
(3) Contracts for purchases of grains, grass seed and pet food ingredients, used primarily to mitigate risk associated with increases in market prices and commodity availability, may obligate us to make future purchases based on estimated yields. The terms of these contracts vary; some having fixed prices or quantities, others having variable pricing and quantities.
See Note 11 - Long-Term Debt to the consolidated financial statements for description of interest rate terms. 36 (3) Contracts for purchases of grains, grass seed and pet food ingredients, used primarily to mitigate risk associated with increases in market prices and commodity availability, may obligate us to make future purchases based on estimated yields.
We anticipate that our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also investment in our continued implementation of a scalable enterprise-wide information technology platform, will be approximately $70 million - $80 million over the next 12 months.
However, we cannot assure you that these sources will continue to provide us with sufficient liquidity and, should we require it, that we will be able to obtain financing on terms satisfactory to us, or at all. 32 We anticipate that our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also investment in our continued implementation of a scalable enterprise-wide information technology platform, will be approximately $70 million over the next 12 months.
Although not all inclusive, we believe that the following represent the more critical accounting policies, which are subject to estimates and assumptions used in the preparation of our consolidated financial statements. 39 Goodwill Goodwill represents the excess of cost of an acquired business over the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed in a business combination.
Although not all inclusive, we believe that the following represent the more critical accounting policies, which are subject to estimates and assumptions used in the preparation of our consolidated financial statements.
In the current uncertain environment, our employees, customers and consumers will continue to be our priority as we manage our business to deliver long-term growth. 27 Results of Operations (GAAP) The following table sets forth, for the periods indicated, the relative percentages that certain income and expense items bear to net sales: Fiscal Year Ended September 24, 2022 September 25, 2021 September 26, 2020 Net sales 100.0 % 100.0 % 100.0 % Cost of goods sold and occupancy 70.3 70.6 70.4 Gross profit 29.7 29.4 29.6 Selling, general and administrative 21.9 21.7 22.2 Operating income 7.8 7.7 7.4 Interest expense, net (1.7) (1.8) (1.5) Other expense, net (0.1) — (0.2) Income taxes 1.4 1.3 1.2 Net income 4.6 % 4.6 % 4.5 % Fiscal 2022 Compared to Fiscal 2021 Net Sales Net sales for fiscal 2022 increased $34.9 million, or 1.1%, to $3,338.6 million from $3,303.7 million in fiscal 2021, due primarily to the impact of recent acquisitions in our Garden segment.
Results of Operations (GAAP) The following table sets forth, for the periods indicated, the relative percentages that certain income and expense items bear to net sales: Fiscal Year Ended September 30, 2023 September 24, 2022 September 25, 2021 Net sales 100.0 % 100.0 % 100.0 % Cost of goods sold and occupancy 71.4 70.3 70.6 Gross profit 28.6 29.7 29.4 Selling, general and administrative 22.2 21.9 21.7 Operating income 6.4 7.8 7.7 Interest expense, net (1.5) (1.7) (1.8) Other expense, net — (0.1) — Income taxes 1.1 1.4 1.3 Net income 3.8 % 4.6 % 4.6 % Fiscal 2023 Compared to Fiscal 2022 Net Sales Net sales for fiscal 2023 decreased $28.5 million, or 0.9%, to $3,310.1 million from $3,338.6 million in fiscal 2022, even with the benefit of an additional week in fiscal 2023 compared to fiscal 2022.
Selling, General and Administrative Selling, general and administrative expenses increased $15.9 million, or 2.2%, from $716.4 million in fiscal 2021 to $732.3 million in fiscal 2022. As a percentage of net sales, selling, general and administrative expenses increased from 21.7% in fiscal 2021 to 21.9% in fiscal 2022; both the Garden segment and corporate contributed to the increased percentage.
Selling, General and Administrative Selling, general and administrative expenses increased $3.9 million, or 0.5%, from $732.3 million in fiscal 2022 to $736.2 million in fiscal 2023. As a percentage of net sales, selling, general and administrative expenses increased from 21.9% in fiscal 2022 to 22.2% in fiscal 2023.
Issuance of $500 million 4.125% Senior Notes due 2030 and Redemption of $400 million 6.125% Senior Notes due 2023 In October 2020, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030 (the "2030 Notes").
We were in compliance with all financial covenants as of September 30, 2023. 33 Issuance of $500 million 4.125% Senior Notes due 2030 In October 2020, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030 (the "2030 Notes").
In fiscal 2022, our operating income was $260 million 26 consisting of income from our Pet segment of $209 million, income from our Garden segment of $154 million and corporate expenses of $103 million . Fiscal 2022 Financial Highlights Financial summary: • Net sales for fiscal 2022 increased $34.9 million, or 1.1%, to $3,339 million.
In fiscal 2023, our operating income was $211 million, consisting of income from our Pet segment of $198 million, income from our Garden segment of $123 million and corporate expenses of $111 million. Fiscal 2023 Financial Highlights Financial summary: • Net sales for fiscal 2023 decreased $28.5 million, or 0.9%, to $3,310 million.
Recent Accounting Pronouncements Refer to the discussion under Part II, Item 8, Notes to Consolidated Financial Statements, Note 1 – Organization and Significant Accounting Policies for a summary of recent accounting pronouncements.
Potential performance-based periods extend through fiscal 2025 for Hydro-Organics Wholesale, Inc. and the payments are capped at $1.0 million per year. Recent Accounting Pronouncements Refer to the discussion under Part II, Item 8, Notes to Consolidated Financial Statements, Note 1 – Organization and Significant Accounting Policies for a summary of recent accounting pronouncements.
During fiscal 2021, we acquired DoMyOwn for approximately $81 million, Hopewell Nursery for approximately $81 million, Green Garden Products for approximately $571 million and D&D Commodities for approximately $88 million. Net cash used in investing activities increased $851.3 million from $48.1 million in fiscal 2020 to $899.4 million in fiscal 2021.
During fiscal 2021, we acquired DoMyOwn for approximately $81 million, Hopewell Nursery for approximately $81 million, Green Garden Products for approximately $571 million and D&D Commodities for approximately $88 million. Financing Activities Net cash used by financing activities decreased $29.2 million from $66.8 million of cash used in fiscal 2022 to $37.6 million of cash used in fiscal 2023.
Identifiable intangible assets acquired in business combinations are recorded based on their fair values at the date of acquisition. Goodwill and identifiable intangible assets with indefinite lives are not subject to amortization but must be evaluated for impairment.
Goodwill and identifiable intangible assets with indefinite lives are not subject to amortization but must be evaluated for impairment.
Pet operating income increased $0.7 million, or 0.3%, to $208.9 million in fiscal 2022 from $208.2 million in fiscal 2021. Pet operating income increased due to lower selling, general and administrative expense partially offset by a decrease in net sales.
Pet operating income decreased $10.9 million, or 5.2%, to $198.0 million in fiscal 2023 from $208.9 million in fiscal 2022. Pet operating income decreased due to slightly lower sales, a decrease in gross margin and increased selling, general and administrative expenses. Pet operating margin decreased from 11.1% in fiscal 2022 to 10.5% in fiscal 2023.
Non-GAAP financial measures reflect adjustments based on the following items: • Incremental expenses from note redemption and issuance: we have excluded the impact of the incremental expenses incurred from the note redemption and issuance as they represent an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods.
Non-GAAP financial measures reflect adjustments based on the following items: • Facility closures: we exclude the impact of the closure of facilities as they represent infrequent transactions that occur in limited circumstances that impact the comparability between operating periods.
Considerable judgment and estimates are required to determine such amounts, particularly as they relate to identifiable intangible assets, and the applicable useful lives related thereto. Under different assumptions, the resulting valuations could be materially different, which could materially impact the operating results we report. 40 Our contractual commitments are presented under the caption Liquidity and Capital Resources.
Under different assumptions, the resulting valuations could be materially different, which could materially impact the operating results we report. Our contractual commitments are presented under the caption Liquidity and Capital Resources.
Net cash provided by financing activities increased $481.0 million from $60.6 million of cash used in fiscal 2020 to $420.5 million cash provided in fiscal 2021.
Net cash used in operating activities increased $284.8 million, from $250.8 million of cash provided by operating activities in fiscal 2021 to $34.0 million of cash used in operating activities in fiscal 2022.
An unused line fee shall be payable quarterly in respect of the total amount of the unutilized Lenders’ commitments and short-notice borrowings under the Amended Credit Facility.
The applicable margin for SOFR-based borrowings fluctuates between1.00%-1.50%, and was 1.0% as of September 30, 2023, and the applicable margin for Base Rate borrowings fluctuates between 0.00%-0.50%, and was 0.00% as of September 30, 2023. An unused line fee shall be payable quarterly in respect of the total amount of the unutilized Lenders’ commitments under the Amended Credit Facility.
Summarized Statements of Operations (in thousands) Fiscal Year Ended Fiscal Year Ended September 24, 2022 September 25, 2021 (in thousands) Parent/Issuer Guarantors Parent/Issuer Guarantors Net sales $ 819,213 $ 2,198,460 $ 908,599 $ 2,142,925 Gross profit $ 183,090 $ 709,635 $ 205,837 $ 686,332 Income (loss) from operations $ (12,305) $ 243,293 $ 4,382 $ 229,961 Equity in earnings of Guarantor subsidiaries $ 189,228 $ — $ 183,122 $ — Net income (loss) $ (53,968) $ 189,228 $ (45,596) $ 183,122 Summarized Balance Sheet Information (in thousands) As of As of September 24, 2022 September 25, 2021 (in thousands) Parent/Issuer Guarantors Parent/Issuer Guarantors Current assets $ 455,381 $ 904,090 $ 670,030 $ 733,132 Intercompany receivable from Non-guarantor subsidiaries 309,238 61,794 229,795 61,633 Other assets 3,124,526 2,458,823 2,896,162 2,399,165 Total assets $ 3,889,145 $ 3,424,707 $ 3,795,987 $ 3,193,930 Current liabilities $ 162,793 $ 267,872 $ 185,996 $ 298,039 Long-term debt 1,185,891 — 1,184,024 — Other liabilities 1,450,702 220,990 1,272,798 151,011 Total liabilities $ 2,799,386 $ 488,862 $ 2,642,818 $ 449,050 38 Contractual Obligations The table below presents our significant contractual cash obligations by fiscal year: Contractual Obligations Fiscal 2023 Fiscal 2024 Fiscal 2025 Fiscal 2026 Fiscal 2027 Thereafter Total (in millions) Long-term debt, including current maturities (1) $ 0.3 $ 0.2 $ 0.1 $ — $ — $ 1,200.0 $ 1,200.6 Interest payment obligations (2) 52.5 52.5 52.5 52.5 52.5 137.6 400.1 Operating leases 52.6 46.3 37.3 24.9 15.4 38.3 214.8 Purchase commitments (3) 184.8 47.1 26.0 16.1 9.0 2.2 285.2 Performance-based payments (4) — — — — — — — Total $ 290.2 $ 146.1 $ 115.9 $ 93.5 $ 76.9 $ 1,378.1 $ 2,100.7 (1) Excludes $1.3 million of outstanding letters of credit related to normal business transactions.
The summarized information excludes financial information of the Non-Guarantors, including earnings from and investments in these entities. 35 Summarized Statements of Operations (in thousands) Fiscal Year Ended Fiscal Year Ended September 30, 2023 September 24, 2022 (in thousands) Parent/Issuer Guarantors Parent/Issuer Guarantors Net sales $ 768,207 $ 2,531,503 $ 819,213 $ 2,198,460 Gross profit $ 166,370 $ 767,480 $ 183,090 $ 709,635 Income (loss) from operations $ (32,001) $ 244,164 $ (12,305) $ 243,293 Equity in earnings of Guarantor subsidiaries $ 191,793 $ — $ 189,228 $ — Net income (loss) $ (63,840) $ 191,793 $ (53,968) $ 189,228 Summarized Balance Sheet Information (in thousands) As of As of September 30, 2023 September 24, 2022 (in thousands) Parent/Issuer Guarantors Parent/Issuer Guarantors Current assets $ 661,660 $ 999,218 $ 455,381 $ 904,090 Intercompany receivable from Non-guarantor subsidiaries 69,404 — 309,238 61,794 Other assets 3,402,000 2,762,797 3,124,526 2,458,823 Total assets $ 4,133,064 $ 3,762,015 $ 3,889,145 $ 3,424,707 Current liabilities $ 155,793 $ 294,686 $ 162,793 $ 267,872 Intercompany payable from Non-guarantor subsidiaries — 766 Long-term debt 1,187,771 186 1,185,891 — Other liabilities 1,308,736 60,611 1,450,702 220,990 Total liabilities $ 2,652,300 $ 356,249 $ 2,799,386 $ 488,862 Contractual Obligations The table below presents our significant contractual cash obligations by fiscal year: Contractual Obligations Fiscal 2024 Fiscal 2025 Fiscal 2026 Fiscal 2027 Fiscal 2028 Thereafter Total (in millions) Long-term debt, including current maturities (1) $ 0.2 $ 0.2 $ 0.1 $ — $ — $ 1,200.0 $ 1,200.5 Interest payment obligations (2) 52.5 52.5 52.5 52.5 52.5 92.8 355.3 Operating leases 54.9 47.1 33.0 22.8 14.7 34.8 207.3 Purchase commitments (3) 138.9 36.4 21.4 13.0 5.9 2.4 218.0 Performance-based payments (4) — — — — — — — Total $ 246.5 $ 136.2 $ 107.0 $ 88.3 $ 73.1 $ 1,330.0 $ 1,981.1 (1) Excludes $1.3 million of outstanding letters of credit related to normal business transactions.
The valuations employ present value techniques to measure fair value and consider market factors. Our goodwill is associated with our Pet segment and our Garden segment.
The valuations employ present value techniques to measure fair value and consider market factors. Our goodwill is associated with our Pet segment and our Garden segment. In connection with our annual goodwill impairment testing performed during fiscal 2023, we elected to bypass the qualitative assessment and proceeded directly to performing the quantitative goodwill 37 impairment test.
Warehouse and administrative expense increased $21.5 million, or 6.1%, to $374.2 million in fiscal 2022 and increased as a percentage of net sales to 11.2% in fiscal 2022 from 10.7% in fiscal 2021. The increased expense was driven by the addition of our four fiscal 2021 acquisitions in the Garden segment and increased rent expense at several facilities.
Warehouse and administrative expense increased $24.5 million, or 6.6%, to $398.7 million in fiscal 2023 and increased as a percentage of net sales to 12.0% in fiscal 2023 from 11.2% in fiscal 2022. The increase in warehouse and administrative expense was primarily in the Pet segment and secondarily in Corporate.
The Amended Credit Facility provides for the transition from LIBOR to Secured Overnight Financing Rate ("SOFR") and does not require an amendment in connection with such transition. As of September 24, 2022, the applicable interest rate related to Base Rate borrowings was 6.3%, and the applicable interest rate related to one-month LIBOR-based borrowings was 4.1%.
The Amended Credit Facility was amended on May 15, 2023 to transition from LIBOR to SOFR. As of September 30, 2023, the applicable interest rate related to Base Rate borrowings was 8.5%, and the applicable interest rate related to one-month SOFR-based borrowings was 6.3%.
The 2031 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our Amended Credit Facility. The 2031 Notes were issued in a private placement under Rule 144A and will not be registered under the Securities Act of 1933.
The debt issuance costs are being amortized over the term of the 2031 Notes. The 2031 Notes require semi-annual interest payments on April 30 and October 30. The 2031 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our Amended Credit Facility.
For certain agreements, management estimates are used to develop the quantities and pricing for anticipated purchases, and future purchases could vary significantly from such estimates. (4) Possible performance-based payments associated with prior acquisitions of businesses are not included in the above table, because they are based on future performance of the businesses acquired, which is not yet known.
(4) Possible performance-based payments associated with prior acquisitions of businesses are not included in the above table, because they are based on future performance of the businesses acquired, which is not yet known. Performance-based payments of approximately $0.1 million were made in fiscal 2023 related to Hydro-Organics Wholesale, Inc.
Debt outstanding on September 24, 2022 was $1,186.6 million compared to $1,185.8 million as of September 25, 2021. Our average borrowing rate for fiscal 2022 was 4.5% compared to 4.4% for fiscal 2021. Other Expense Other expense is comprised of income or loss from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses.
Other Income (Expense) Other income (expense) is comprised of income or loss from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses.
Although our gross and operating margins increased in fiscal 2022, rising costs are making it difficult for us to further increase prices to our customers at a pace sufficient for us to maintain our margins. In fiscal 2022, we continued to experience increasing inflationary pressure, including notable increases in costs for key commodities, materials, labor and freight.
In fiscal 2023, we continued to experience inflationary pressures, although at a reduced rate in the latter months of the fiscal year. In fiscal 2022, we continued to experience increasing inflationary pressure, including notable increases in costs for key commodities, materials, labor and freight.
We believe the adjustment of this loss supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
We believe that the adjustment of these charges supplements the GAAP information with a measure that can be used to assess the performance of our ongoing operations. • Tax impact: adjustment represents the impact of the tax effect of the pre-tax non-GAAP adjustments excluded from non-GAAP net income.
Senior Notes Issuance of $400 million 4.125% Senior Notes due 2031 In April 2021, we issued $400 million aggregate principal amount of 4.125% senior notes due April 2031 (the "2031 Notes"). We used the net proceeds from the offering to repay all outstanding borrowings under our Amended Credit Facility, with the remainder used for general corporate purposes.
We used a portion of the net proceeds from the offering to repay all outstanding borrowings under our Amended Credit Facility, with the remainder used for general corporate purposes. We incurred approximately $6 million of debt issuance costs in conjunction with this issuance, which included underwriter fees and legal, accounting and rating agency expenses.
Our branded product sales, which include products we produce under Central brand names and products we produce under third-party brands, increased $53.8 million to $2.6 billion, and sales of other manufacturers’ products decreased $18.9 million to $730 million. Sales of branded products represented 78% of our net sales in fiscal 2022 compared with 77% in fiscal 2021.
Our branded product sales, which include products we produce under Central brand names and products we produce under third-party brands, decreased $33.2 million, and sales of other manufacturers’ products increased $4.7 million. The decline in branded sales was due primarily to lower sales of private label products we produce under third-party brands in both the Garden and Pet segments.
The increase in cash used in investing activities was due primarily to acquisition activity and an increase in capital expenditures of approximately $37 million in fiscal 2021 compared to fiscal 2020, partially offset by proceeds received from the sale of our Breeder's Choice business during the first quarter of fiscal 2021 and decreased investments in fiscal 2021 compared to fiscal 2020.
Investing Activities Net cash used in investing activities decreased $108.4 million from $143.0 million in fiscal 2022 to $34.6 million in fiscal 2023. The decrease in cash used in investing activities was due primarily to reduced capital expenditures, decreased investments in fiscal 2023 compared to fiscal 2022, and proceeds received from the sale of our independent garden center distribution business.
Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resource, and information technology functions. Selling and delivery expense decreased $5.6 million, or 1.5%, to $358.1 million in fiscal 2022 and decreased as a percentage of net sales from 11.0% in fiscal 2021 to 10.7% in fiscal 2022.
Selling and delivery expense decreased $20.6 million, or 5.8%, to $337.5 million in fiscal 2023 and decreased as a percentage of net sales from 10.7% in fiscal 2022 to 10.2% in fiscal 2023.
Gross margin improved 30 basis points in fiscal 2022 to 29.7%, from 29.4% in fiscal 2021. • Our operating income increased $5.5 million, or 2.2%, to $260.0 million in fiscal 2022, and as a percentage of net sales improved to 7.8% from 7.7% in fiscal 2021. • Net income for fiscal 2022 was $152.2 million, or $2.80 per share on a diluted basis, compared to net income in fiscal 2021 of $151.7 million, or $2.75 per share on a diluted basis.
Net Income and Earnings Per Share Our net income for fiscal 2023 was $125.6 million, or $2.35 per diluted share, compared to $152.2 million, or $2.80 per diluted share, for fiscal 2022. On a non-GAAP basis, net income in fiscal 2023 was $138.5 million, or $2.59 per diluted share.
Our Pet segment sales decreased 0.9%, and our Garden segment sales increased 3.7%. • Organic net sales declined 3.3%, due primarily to a 6.8% decline in our Garden segment. • Gross profit for fiscal 2022 increased $21.4 million, or 2.2%, to $992.3 million.
The decline in sales was primarily in our Garden segment, the sales of which decreased $27.6 million, or 1.9%. • Gross profit for fiscal 2023 decreased $45.5 million, or 4.6%, to $946.8 million. Gross margin declined 110 basis points in fiscal 2023 to 28.6%, from 29.7% in fiscal 2022.
Our expected revenues were based on our future operating plan and market growth or decline estimates for future years. No impairment was indicated during our fiscal 2022, 2021 and 2020 analyses of our indefinite-lived trade names and trademarks. Acquisitions In connection with businesses we acquire, management must determine the fair values of assets acquired and liabilities assumed.
Our expected revenues were based on our future operating plan and market growth or decline estimates for future years. We recognized impairment losses on certain intangible assets of $11.5 million in fiscal year 2023, and there were no impairment losses recorded in fiscal years 2021 and 2022.
Pet branded sales decreased $25.9 million, and sales of other manufacturers' products increased $9.1 million. 28 Garden net sales increased $51.7 million, or 3.7%, to $1,460.5 million in fiscal 2022 from $1,408.8 million in fiscal 2021.
These declines were partially offset by 26 increased sales in our dog and cat treats and toys business and our wild bird feed business. Pet branded sales decreased $14.1 million, and sales of other manufacturers' products increased $13.2 million. Garden net sales decreased $27.6 million, or 1.9%, to $1,432.9 million in fiscal 2023 from $1,460.5 million in fiscal 2022.
Sales of other manufacturers' products represented the balance of our net sales.
Sales of branded products represented 78% of our net sales in both fiscal 2023 and fiscal 2022. Sales of other manufacturers' products represented 22% of our net sales.